Resistance to the HIV Protease Inhibitor Amprenavir In Vitro and in Clinical Studies: A Review

Author： Tisdale M.   Myers R.   Randall S.   Maguire M.   Ait-Khaled M.   Elston R.   Snowden W.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.20, Iss.4, 2000-10, pp. : 267-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acquisition of Multi-PI (Protease Inhibitor) Resistance in HIV-1 In Vivo and In Vitro

By  

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4055-4064

Bentham Science Publishers

Access to resources Recommend Favorite

Amprenavir: A Review of its Clinical Potential in Patients with HIV Infection

By Noble S.   Goa K.L.  

Drugs, Vol. 60, Iss. 6, 2000-12 ,pp. : 1383-1410

Adis International

Access to resources Recommend Favorite

Review of atazanavir: a novel HIV protease inhibitor

By Fuster Daniel   Clotet Bonaventura  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1565-1572

Informa Healthcare

Access to resources Recommend Favorite

Review of HIV-1 Protease Inhibitor Assay Methods

By  

Current Pharmaceutical Analysis, Vol. 3, Iss. 3, 2007-08 ,pp. : 180-185

Bentham Science Publishers

Access to resources Recommend Favorite

Resistance to HIV Protease Inhibitors: Mechanisms and Clinical Consequences

By  

Current Drug Metabolism, Vol. 5, Iss. 4, 2004-08 ,pp. : 321-328

Bentham Science Publishers

Access to resources Recommend Favorite